NCT02096302

The Effects of an Infant Formula Containing Probiotic CECT7210 on Gastrointestinal Health

Evaluar el Efecto de Una fórmula Infantil Enriquecida Con el probiótico CECT7210 Sobre la Incidencia de Infecciones Gastrointestinales

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 194 (actual)
• Sponsor: Laboratorios Ordesa · Industry
• Sex: All
• Age: 90 Days
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine whether an infant formula supplemented with a new probiotic CECT7210, is effective in reducing the incidence of infections, specially the gastrointestinal ones.

Detailed description

This a multicenter, controlled, randomized, prospective, parallel, double-blinded study to evaluate the effect of an infant formula containing a new probiotic, Bifidobacterium longum biovar infantis CECT7210, on the incidence of diarrhea in healthy infants born at term. Infants will be randomized to take an standard infant formula or the infant formula with the probiotic CECT7210 during 12 weeks.

Conditions

• Gastrointestinal Diseases

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Infant Formula with a novel probiotic CECT7210	Bottle-feeding with a new infant formula enriched with probiotic CECT7210 during the first 3 months of life.
DIETARY_SUPPLEMENT	Standard formula	Standard formula without probiotics

Timeline

• Start date: 2011-01-01
• Primary completion: 2012-11-01
• Completion: 2013-06-01
• First posted: 2014-03-26
• Last updated: 2019-07-19

Locations

3 sites across 1 country: Spain